Lebowitz Peter F
SEC insider (Form 3/4/5 filer). CIK 0002121402. Director at BridgeBio Oncology Therapeutics, Inc. (BBOT). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Lebowitz Peter F has filed insider reports for
- BridgeBio Oncology Therapeutics, Inc. (BBOT): Director
Lebowitz Peter F
CIK: 0002121402
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BBOT
BridgeBio Oncology Therapeutics, Inc.
Director